Skip to content

Celcuity CELC Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Gilead Sciences logo
Gilead SciencesGILD
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Tango Therapeutics logo
Tango TherapeuticsTNGX
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
Exelixis logo
ExelixisEXEL

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.4B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's common stock, shares, outstanding?
Celcuity (CELC) reported common stock, shares, outstanding of $48.35M in Q1 2026.
How has Celcuity's common stock, shares, outstanding changed year-over-year?
Celcuity's common stock, shares, outstanding increased by 27.8% year-over-year, from $37.84M to $48.35M.
What is the long-term trend for Celcuity's common stock, shares, outstanding?
Over 5 years (2020 to 2025), Celcuity's common stock, shares, outstanding has grown at a 36.2% compound annual growth rate (CAGR), from $10.3M to $48.24M.